VACCINES AS A PRODUCT OF INDUSTRIAL BIOTECHNOLOGIES AND A SPECIAL COMMODITY IN THE INTERNATIONAL BIOPHARMACEUTICALS MARKET
https://doi.org/10.21686/2410-7395-2023-3-87-100
Abstract
Global biopharmaceutical market state is currently of particular importance not only as a primary economic characteristic and a condition for the successful healthcare organization in different countries, but also as a safety from possible pandemics guarantee. Various vaccines production plays a special role becoming one of the modern bioeconomy sectors. The bioeconomy, as an activity, is based on industrial biotechnologies and new knowledgebased approaches for the efficient bioproducts production derived from natural resources, and is focused on solving various environmental, as well as political and even social issues for sustainable development. The purpose of the article is to study the general trends in the production and turnover of vaccines on the biopharmaceutical market, taking into account the COVID-19 pandemic. Data on vaccination complications and manifestations of pharmaceutical companies' competition in the vaccine market with various consequences are presented. It is concluded that the effective functioning of the global vaccine market can be considered as an important element of sustainable development on the way to achieving the protection of citizens from dangerous diseases and ensuring social welfare due to the development of biotechnologies.
About the Authors
E. S. Titova
Plekhanov Russian University of Economics
Russian Federation
Russian Federation
Ekaterina S. Titova, PhD, Leading Researcher of the Education Development Research Institute of the PRUE
36 Stremyanny Lane, Moscow, 115054
S. S. Shishkin
Federal Research Centre “Fundamentals of biotechnology” of the Russian Academy of Sciences
Russian Federation
Russian Federation
Sergey S. Shishkin, Doctor of Biological Sciences, Professor,
Senior Researcher of the Analytical Group of the Research Centre of Biotechnology RAS
33, Building 2, Leninsky Prospect, Moscow, 119071
References
1. Arsenteva I. I. Transformatsiya meditsinskoy i vaktsinnoy diplomatii v epokhu COVID-19 [Transformation of Medical and Vaccine Diplomacy in the Era of COVID-19]. Vestnik MGIMO-Universiteta [Bulletin of MGIMOUniversity], 2022, Vol. 15, No. 5, pp. 182–207. (In Russ.).
2. Goroshko N. V., Patsala S. V., Emelyanova E. K. Rynok COVID-19- vaktsin kak novyy segment mirovogo vaktsinnogo rynka [The Market for COVID-19 Vaccines as a New Segment of the Global Vaccine Market]. Vestnik Kemerovskogo gosudarstvennogo universiteta. Seriya: Politicheskie, sotsiologicheskie i ekonomicheskie nauki [Bulletin of the Kemerovo State University. Series: Political, Sociological and Economic Sciences], 2021, Vol. 6, No. 2 (20), pp. 178– 190. (In Russ.).
3. Narkevich I. A., Trukhin V. P., Basakina I. I., Barabanova A. I., Terninko T. M. Analiz struktury i assortimenta vaktsin na Rossiyskom farmatsevticheskom rynke [Analysis of the Structure and Range of Vaccines in the Russian Pharmaceutical Market]. Vestnik Voronezhskogo gosudarstvennogo universiteta. Seriya: Khimiya. Biologiya. Farmatsiya. [Bulletin of the Voronezh State University. Series: Chemistry. Biology. Pharmacy]. 2019, No. 4, pp. 94– 100. (In Russ.).
4. Operativnye dannye o COVID-19 [Operational Data on COVID-19]. (In Russ.). Available at: https://xn--80aesfpebagmfblc0a.xn--p1ai/
5. Pogarskaya A. S., Konfino K. V. Realizatsiya podkhoda kholodovoy tsepi pri transportirovke i khranenii immunobiologicheskikh preparatov [Implementation of the Cold Chain Approach in the Transportation and Storage of Immunobiological Preparations]. Problemy sotsialnoy gigieny, zdravookhraneniya i istorii meditsiny [Problems of Social Hygiene, Health Care and the History of Medicine], 2022, No. 30 (4), pp. 666–672. (In Russ.). DOI: 10.32687/0869-866X-2022-30-4-666-672
6. Titova E. S., Shishkin S. S., Shtykhno D. A. Bioekonomika – odin iz putey k ustoychivomu razvitiyu regionov [Bioeconomy as One of the Ways to Sustainable Development of Russian Regions]. Federalizm [Federalizm], 2023, Vol. 28, No. 1 (109), pp. 56–79. (In Russ.). DOI: 10.21686/2073-1051-2023-1-56-79
7. 40 let bez ospy. V VOZ napominayut o vazhnom dostizhenii chelovechestva [40 Years without Smallpox. WHO Reminds about the Important Achievement of Mankind]. (In Russ.). Available at: https://news. un.org/ru/story/2019/12/1368841
8. Aguilar A., Bochereau L., Matthiessen L. Biotechnology as the Engine for the Knowledge-Based Bio-Economy. Biotechnology & Genetic Engineering Reviews, 2010, Vol. 26, pp. 371–388. DOI: 10.5661/bger-26-371
9. Bayani F., Hashkavaei N. S., Arjmand S. et al. An Overview of the Vaccine Platforms to Combat COVID-19 with a Focus on the Subunit Vaccines. Progress in Biophysics and Molecular Biology, 2023, Vol. 178, pp 32–49. DOI: 10.1016/j.pbiomolbio.2023.02.004
10. Catalani V., Townshend H. D., Prilutskaya M. et al. Profiling the Vendors of COVID-19 Related Product on the Darknet: an Observational Study. Emerging Trends in Drugs, Addictions and Health, 2023, Vol. 3, p. 100051. DOI: 10.1016/j.etdah.2023.100051
11. Deshar P. A Global Look into the Prospects of Bioeconomy. Yrkeshögskolan Novia, 2016. Available at: http://www.theseus.fi/handle/ 10024/115759
12. Huddart J. E. A., Crawford A. J., Luna-Tapia A. L. et al. EBPColombia and the Bioeconomy: Genomics in the Service of Biodiversity Conservation and Sustainable Development. Proceedings of the National Academy of Sciences of the USA, 2022, Vol. 119 (4), p. e2115641119. DOI: 10.1073/ pnas.2115641119
13. Leigang Jin, Leiluo Geng, Ranyao Yang, Aimin Xu. Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications. Annual Review of Pharmacology and Toxicology, 2023, Vol. 63, p. 359–382. DOI: 10.1146/annurev-pharmtox-032322-093904
14. Kesik-Brodacka M. Progress in Biopharmaceutical Development. Biotechnology and Applied Biochemistry, 2018, Vol. 65 (3), p. 306–322. DOI: 10.1002/bab.1617
15. Kircher M., Maurer K-H. Herzberg D. KBBE: The Knowledge-Based Bioeconomy: Concept, Status and Future Prospects. EFB Bioeconomy Journal, 2022, Vol. 2, p. 100034. DOI: 10.1016/j.bioeco.2022.100034
16. Kumar V., Kumar S., Sharma P. C. Recent Advances in the Vaccine Development for the Prophylaxis of SARS Covid-19. International Immunopharmacology, 2022, Vol. 111, p. 109175. DOI: 10.1016/j.intimp. 2022.109175
17. Logunov D. Y., Dolzhikova I. V., Shcheblyakov D. V. et al. GamCOVID-Vac Vaccine Trial Group. Safety and Efficacy of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine: an Interim Analysis of a Randomised Controlled Phase 3 Trial in Russia. Lancet, 2021, Vol. 397 (10275), pp. 671–681. DOI: 10.1016/S0140-6736(21)00234-8
18. Miao G., Chen Z., Cao H. et al. From Immunogen to COVID-19 Vaccines: Prospects for the Post-Pandemic Era. Biomedicine & Pharmacotherapy, 2023, Vol. 158, p. 114208. DOI: 10.1016/j.biopha. 2022.114208
19. Mitragotri S., Burke P. A., Langer R. Overcoming the Challenges in Administering Biopharmaceuticals: Formulation and Delivery Strategies. Nature Reviews Drug Discovery, 2014, Vol. 13 (9), pp. 655–672. DOI: 10.1038/ nrd4363
20. Ndwandwe D., Wiysonge C. S. COVID-19 vaccines. Current Opinion in Immunology, 2021, Vol. 71, pp. 111–116. DOI: 10.1016/j.coi.2021.07.003
21. Nielsen J., Tillegreen C. B., Petranovic D. Innovation trends in industrial biotechnology. Trends in Biotechnology, 2022, Vol. 40 (10), pp. 1160– 1172. DOI: 10.1016/j.tibtech.2022.03.007
22. Pavli A., Maltezou H. C. Travel vaccines throughout history. Travel Medicine and Infectious Disease, 2022, Vol. 46, p. 102278. DOI: 10.1016/j.tmaid. 2022.102278
23. Pollet J., Chen W. H., Strych U. Recombinant Protein Vaccines, a Proven Approach Against Coronavirus Pandemics. Advanced Drug Delivery Reviews, 2021, Vol. 170, pp. 71–82. DOI: 10.1016/j.addr. 2021.01.001
24. Song T. J., Shin J. I., Yon D. K. et al. Cerebral Venous Thrombosis after ChAdOx1 nCoV-19 Vaccination: a Systematic Review. European Review for Medical and Pharmacological Sciences, 2023, Vol. 27 (1), pp. 404–410. DOI: 10.26355/eurrev_202301_30894
25. Wohlgemuth R., Twardowski T., Aguilar A. Bioeconomy Moving Forward Step by Step – a Global Journey. New Biotechnology, 2021, Vol. 61, pp. 22–28. DOI: 10.1016/j.nbt.2020.11.006
Review
For citations:
Titova E.S., Shishkin S.S. VACCINES AS A PRODUCT OF INDUSTRIAL BIOTECHNOLOGIES AND A SPECIAL COMMODITY IN THE INTERNATIONAL BIOPHARMACEUTICALS MARKET. International Trade and Trade Policy. 2023;9(3):87-100. (In Russ.) https://doi.org/10.21686/2410-7395-2023-3-87-100
Views:
304
Email this article 
